Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.59 |
| ▸ | KMO | O15229 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 3/20 | 0.54 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.54 |
| ▸ | DRD4 | P21917 | 2/20 | 0.54 |
| ▸ | DRD3 | P35462 | 2/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | PRCP | P42785 | 1/20 | 0.54 |
| ▸ | EBP | Q15125 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4959143 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL3356779 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL4962000 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL4961955 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL5272910 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL31123519 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL1982025 | 1.00 | HDAC4 (0.59) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL28703324 | 0.98 | HDAC4 (0.58) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL1661863 | 0.98 | HDAC4 (0.61) | HDAC4HDAC2HDAC8KMODRD2 | |
| SCHEMBL1658753 | 0.94 | HDAC4 (0.56) | HDAC4HDAC2HDAC8DRD2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114276530-B | Intermittent phosgene interface method preparation process and application of polycarbonate | 广州市德力塑化工科技有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-114276530-A | Intermittent phosgene interface method preparation process of polycarbonate and application thereof | 深圳市德力塑化工科技有限公司 | 2022-04-05 | — | — | CN | claimed |
| EP-3215269-B1 | PROCESS FOR PRODUCING ORTHOPHENYLPHENOL (OPP) | LANXESS DEUTSCHLAND GMBH (DE) | 2020-05-13 | — | — | EP | claimed |
| EP-3053992-A1 | Biodiesel | LANXESS Deutschland GmbH (DE) | 2016-08-10 | — | — | EP | claimed |
| EP-2684900-B1 | RADICALLY CURABLE COMPOUND, CURED PRODUCT OF SAME, AND METHOD FOR PRODUCING SAME | DAINIPPON INK & CHEMICALS (JP) | 2016-03-02 | — | — | EP | claimed |
| US-8816033-B2 | Radically curable compound, cured product thereof, and method for producing the compound | DIC CORPORATION (JP) | 2014-08-26 | — | — | US | claimed |
| US-20130338329-A1 | RADICALLY CURABLE COMPOUND, CURED PRODUCT THEREOF, AND METHOD FOR PRODUCING THE COMPOUND | DIC CORPORATION (JP) | 2013-12-19 | — | — | US | claimed |
| US-5322919-A | Transesterification in an inert solvent | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1994-06-21 | — | — | US | claimed |
| US-3932536-A | DEHYDROGENATION CATALYST, NI, CR, AL, CU, 1A SULFATE OR CARBONATE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-13 | — | — | US | claimed |
| JP-4193863-A | — | — | None | — | — | JP | disclosed |
| US-20260001987-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-01-01 | — | — | US | disclosed |
| US-12486239-B2 | Benzotriazole compound, light absorber, and resin composition | MITSUI CHEMICALS, INC. (JP) | 2025-12-02 | — | — | US | disclosed |
| US-12460048-B2 | Thermoplastic resin composition and formed product | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-11-04 | — | — | US | disclosed |
| EP-4023698-B1 | THERMOPLASTIC RESIN COMPOSITION AND FORMED PRODUCT | MITSUBISHI CHEM CORP (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-4075220-A | FOR POLYMERS | EASTMAN KODAK COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
| US-4013708-A | ANTIALLERGENS | CIBA-GEIGY CORPORATION (US) | 1977-03-22 | — | — | US | disclosed |
| US-4013690-A | ORGANIC COMPOUNDS | SANDOZ LTD. (CH) | 1977-03-22 | — | — | US | disclosed |
| US-3957813-A | BENZOXAZOLYL PHENYL AROMATIC ESTER COMPOUNDS AND THEIR USE AS ULTRAVIOLET STABILIZERS IN ORGANIC COMPOSITIONS | EASTMAN KODAK COMPANY (US) | 1976-05-18 | — | — | US | disclosed |
| US-3933924-A | Process for preparing hydroxydiphenyl | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-20 | — | — | US | disclosed |
| US-3932536-A | DEHYDROGENATION CATALYST, NI, CR, AL, CU, 1A SULFATE OR CARBONATE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130338329-A1 | RADICALLY CURABLE COMPOUND, CURED PRODUCT THEREOF, AND METHOD FOR PRODUCING THE COMPOUND | CBR1, HEATR1, MTR | HDAC4 827/4885HDAC2 1144/4885HDAC8 1476/4885 |
| US-20260001987-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | SEM1, WDR1, TAF1 | HDAC4 1002/4885HDAC2 803/4885HDAC8 652/4885 |
| US-12486239-B2 | Benzotriazole compound, light absorber, and resin composition | SULT1A1, BET1, SULT1E1 | HDAC4 462/4885HDAC2 330/4885HDAC8 1140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.